Long-Term Fatigue Can Persist for Up to a Year After a Mini-Stroke

New research reveals that fatigue can last up to a year after a transient ischemic attack, highlighting the importance of follow-up care for TIA patients.
Transient ischemic attacks (TIAs), commonly known as 'ministrokes,' can have lasting effects beyond the immediate neurological symptoms. Recent research indicates that more than half of individuals who experience a TIA may suffer from fatigue that persists for up to a year after the event. The study highlights the importance for healthcare providers to monitor and address fatigue in TIA patients, as it can significantly impact recovery and quality of life.
The research, published in Neurology and conducted by Danish researchers, involved tracking fatigue levels in patients shortly after their TIA and during follow-up visits at 3, 6, and 12 months. Results showed that over 60% of patients experienced pathological fatigue at the start of the study, with more than half continuing to report fatigue after a year. Interestingly, factors such as the presence of acute infarction or a history of anxiety or depression played a role in fatigue outcomes.
This study underscores the need to reconsider post-TIA care, emphasizing ongoing fatigue assessment and management. Healthcare professionals are encouraged to incorporate fatigue evaluations into follow-up protocols, as early identification and intervention could improve long-term outcomes. Experts suggest that rehabilitation and support should be extended to TIA patients similarly to stroke patients, given the comparable fatigue levels observed.
Continued research is necessary to understand why some individuals develop prolonged fatigue after a TIA, and how best to support recovery in these cases.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Experts Highlight the Importance of Reducing Screen Time and Focusing on Infant Brain Development for Better Long-Term Health and Cognitive Outcomes
Research highlights the importance of limiting screen time and promoting face-to-face interaction in infancy to support healthy brain development and improve long-term health outcomes.
Innovative AI Technology Identifies Hidden Cellular Subtypes to Enhance Precision Medicine
A new AI system called CellLENS enhances our understanding of cellular environments, uncovering hidden cell subtypes for more targeted cancer therapies and advancing precision medicine.
Innovative Biomaterial Demonstrates Potential to Reverse Heart Aging
A new hybrid biomaterial developed by researchers shows promise in reversing age-related changes in heart tissue by targeting the extracellular matrix, opening new possibilities for regenerative therapies.
Shorter Treatment Regimens Show Promise for Some Patients with Drug-Resistant Tuberculosis
New clinical research suggests that shorter, tailored treatment regimens can be effective for certain patients with drug-resistant tuberculosis, improving outcomes while reducing treatment duration and toxicity.